electroCore has announced gammaCore Sapphire, the next generation of gammaCore (non-invasive vagus nerve stimulator or nVNS), is now available in the United States. gammaCore is the first FDA cleared, nVNS device for the acute treatment of pain associated with migraine and episodic cluster headache. gammaCore Sapphire is the next generation of gammaCore nVNS therapy, which is designed as a portable, easy-to-use technology.

electroCore has announced the commercial launch of gammaCore (non-invasive vagus nerve stimulator) for the acute treatment of pain associated with episodic cluster headache in adult patients in the United States (U.S.). gammaCore is the first non-invasive, hand-held medical device applied at the neck and sends gentle, patented electrical stimulation through the skin to activate the vagus nerve, resulting in the reduction of pain.

electroCore has announced that the U.S. FDA released the use of gammaCore (non-invasive vagus nerve stimulator) for the acute treatment of pain associated with episodic cluster headache in adult patients. gammaCore transmits a mild electrical stimulation to the vagus nerve through the skin, resulting in a reduction of pain. This is the first FDA product release for electroCore in the U.S.